These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 16685632)

  • 1. [Dual antithrombotic therapy after implantation of coronary stents].
    Schneider H; Weber F; Holzhausen C; Körber T; Ince H; Rehders T; Nienaber CA
    Dtsch Med Wochenschr; 2006 May; 131(19):1105-10. PubMed ID: 16685632
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Dual platelet aggregation inhibition in coronary artery stent implantation--what is evidence-based?].
    Baer FM; Erdmann E
    Dtsch Med Wochenschr; 2007 Jun; 132(23):1275-80. PubMed ID: 17541871
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of concomitant treatment with proton pump inhibitors and clopidogrel on clinical outcome in patients after coronary stent implantation.
    Tentzeris I; Jarai R; Farhan S; Brozovic I; Smetana P; Geppert A; Wojta J; Siller-Matula J; Huber K
    Thromb Haemost; 2010 Dec; 104(6):1211-8. PubMed ID: 20941464
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Optimal duration of antiplatelet therapy in recipients of coronary drug-eluting stents.
    Zimarino M; Renda G; De Caterina R
    Drugs; 2005; 65(6):725-32. PubMed ID: 15819586
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety and efficacy of aspirin, clopidogrel, and warfarin after coronary stent placement in patients with an indication for anticoagulation.
    Orford JL; Fasseas P; Melby S; Burger K; Steinhubl SR; Holmes DR; Berger PB
    Am Heart J; 2004 Mar; 147(3):463-7. PubMed ID: 14999195
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intensive oral antiplatelet therapy for reduction of ischaemic events including stent thrombosis in patients with acute coronary syndromes treated with percutaneous coronary intervention and stenting in the TRITON-TIMI 38 trial: a subanalysis of a randomised trial.
    Wiviott SD; Braunwald E; McCabe CH; Horvath I; Keltai M; Herrman JP; Van de Werf F; Downey WE; Scirica BM; Murphy SA; Antman EM;
    Lancet; 2008 Apr; 371(9621):1353-63. PubMed ID: 18377975
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Double jeopardy: balance between bleeding and stent thrombosis with prolonged dual antiplatelet therapy after drug-eluting stent implantation.
    Yan BP; Gurvitch R; Ajani AE
    Cardiovasc Revasc Med; 2006; 7(3):155-8. PubMed ID: 16945822
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drug insight: antithrombotic therapy after percutaneous coronary intervention in patients with an indication for anticoagulation.
    Helft G; Gilard M; Le Feuvre C; Zaman AG
    Nat Clin Pract Cardiovasc Med; 2006 Dec; 3(12):673-80. PubMed ID: 17122800
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effectiveness of two-year clopidogrel + aspirin in abolishing the risk of very late thrombosis after drug-eluting stent implantation (from the TYCOON [two-year ClOpidOgrel need] study).
    Tanzilli G; Greco C; Pelliccia F; Pasceri V; Barillà F; Paravati V; Pannitteri G; Gaudio C; Mangieri E
    Am J Cardiol; 2009 Nov; 104(10):1357-61. PubMed ID: 19892050
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Optimal platelet inhibition after coronary stent implantation. Current status].
    Silber S; Hoffmeister HM; Bode C
    Herz; 2008 Jun; 33(4):244-53. PubMed ID: 18581073
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [New aspects on "triple therapy" after coronary stent implantation].
    Schlitt A
    Dtsch Med Wochenschr; 2010 Oct; 135(41):2033-6. PubMed ID: 20925012
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rationale and design of a randomized, double-blind, placebo-controlled trial of 6 versus 12 months clopidogrel therapy after implantation of a drug-eluting stent: The Intracoronary Stenting and Antithrombotic Regimen: Safety And EFficacy of 6 Months Dual Antiplatelet Therapy After Drug-Eluting Stenting (ISAR-SAFE) study.
    Byrne RA; Schulz S; Mehilli J; Iijima R; Massberg S; Neumann FJ; ten Berg JM; Schömig A; Kastrati A;
    Am Heart J; 2009 Apr; 157(4):620-4.e2. PubMed ID: 19332187
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clopidogrel for prevention of major cardiac events after coronary stent implantation: 30-day and 6-month results in patients with smaller stents.
    Calver AL; Blows LJ; Harmer S; Dawkins KD; Gray HH; Morgan JH; Simpson IA
    Am Heart J; 2000 Sep; 140(3):483-91. PubMed ID: 10966552
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of triple antiplatelet therapy (aspirin, clopidogrel, and cilostazol) on platelet aggregation and P-selectin expression in patients undergoing coronary artery stent implantation.
    Lee BK; Lee SW; Park SW; Lee SW; Park DW; Kim YH; Lee CW; Hong MK; Kim JJ; Jang S; Chi HS; Park SJ
    Am J Cardiol; 2007 Aug; 100(4):610-4. PubMed ID: 17697815
    [TBL] [Abstract][Full Text] [Related]  

  • 15. "Triple therapy" rather than "triple threat": a meta-analysis of the two antithrombotic regimens after stent implantation in patients receiving long-term oral anticoagulant treatment.
    Zhao HJ; Zheng ZT; Wang ZH; Li SH; Zhang Y; Zhong M; Zhang W
    Chest; 2011 Feb; 139(2):260-270. PubMed ID: 21285053
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Does pre-treatment with aspirin and loading dose clopidogrel obviate the need for glycoprotein IIb/IIIa antagonists during elective coronary stenting? A focus on peri-procedural myonecrosis.
    Claeys MJ; Van der Planken MG; Bosmans JM; Michiels JJ; Vertessen F; Van Der Goten P; Wuyts FL; Vrints CJ
    Eur Heart J; 2005 Mar; 26(6):567-75. PubMed ID: 15618034
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rationale and design of the dual antiplatelet therapy study, a prospective, multicenter, randomized, double-blind trial to assess the effectiveness and safety of 12 versus 30 months of dual antiplatelet therapy in subjects undergoing percutaneous coronary intervention with either drug-eluting stent or bare metal stent placement for the treatment of coronary artery lesions.
    Mauri L; Kereiakes DJ; Normand SL; Wiviott SD; Cohen DJ; Holmes DR; Bangalore S; Cutlip DE; Pencina M; Massaro JM
    Am Heart J; 2010 Dec; 160(6):1035-41, 1041.e1. PubMed ID: 21146655
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Observance of antiplatelet therapy after stent implantation in patients under chronic oral anticoagulant treatment.
    Valencia J; Mainar V; Bordes P; Pineda J; Gómez S; Sogorb F
    J Interv Cardiol; 2008 Jun; 21(3):218-24. PubMed ID: 18422520
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Primary and secondary prevention of cardiovascular disease: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.
    Vandvik PO; Lincoff AM; Gore JM; Gutterman DD; Sonnenberg FA; Alonso-Coello P; Akl EA; Lansberg MG; Guyatt GH; Spencer FA
    Chest; 2012 Feb; 141(2 Suppl):e637S-e668S. PubMed ID: 22315274
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased long term rates of stent thrombosis and mortality in patients given clopidogrel as compared to ticlopidine following coronary stent implantation.
    Wolak A; Amit G; Cafri C; Gilutz H; Ilia R; Zahger D
    Int J Cardiol; 2005 Sep; 103(3):293-7. PubMed ID: 16098392
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.